Biostimulants VC Funding Declines by 86% in 2024

Venture capital funding for biostimulants fell 86% in 2024, totaling $135 million, with over half allocated to early-stage deals. This decline reflects broader trends in agtech and highlights challenges in the sector amid ongoing market uncertainties.

Original excerpt: VC funding to biostimulants dropped 86% in 2024 to just $135 million, with more than half of all capital going to early-stage deals…

Source: AgFunderNews